Introduction Unintentional hypothermia in patients undergoing off pump coronary artery bypass grafting (OPCABG) under general anesthesia (GA) is a known complication. The wide sternotomy wound as well as low ambient operating room temperature further promotes heat loss. The changes in temperature could further be affected by the use of various vasoactive drugs by affecting the thermoregulatory response. This study is aimed to detect the temperature changes and the influence of vasoactive infusions on the temperature in the patients undergoing OPCABG under GA. Aims The main purpose of this article is to assess the core and skin temperature changes during OPCABG surgery and to assess the effect of vasoactive infusion used intraoperatively on the core temperature Settings and Design Single center, nonrandomized, open label, observational study. Methods and material After informed consent and ethical clearance from institutional review board, 151 adult patients undergoing elective OPCABG surgeries under GA were included in the study. A common anesthetic protocol and warming strategy was used in all patients. The core temperature measured with a nasopharyngeal probe and the skin temperature measured at the palmar surface of the right index finger were recorded at induction, at 30 minutes intervals thereafter, and at end surgery. The demographic variables and the duration of surgery were also recorded. The type and dose of vasoactive agents used intraoperatively were also recorded. The study population was divided post hoc into groups and subgroups for further analysis. Results All the patients showed a decrease in core temperature at end surgery. The temperature changes showed an initial exponential decrease in the first hour followed by a gradual decrease subsequently. The peripheral temperature showed a gradual increase from induction to end surgery. The temperature gradients showed a linear decrease with the core temperature and peripheral skin temperature reaching equilibrium at end surgery. The study population was divided into four groups depending on the type of vasoactive drugs received intraoperatively: vasoconstrictor (V), vasodilator (D), mixed vasoconstrictor and vasodilator (M), and no vasoactive drugs (N) group. The patients in the vasoconstrictor group had a higher core temperature at end surgery when compared with vasodilator group. Conclusions OPCABG under GA results in decrease in core temperature. The decrease in temperature is exponential in the initial 1 hour followed by a more gradual decrease. The temperature changes are possibly affected by the vasoactive drugs used intraoperatively. The effect of vasoactive drugs on core temperature is higher when used during the initial exponential decrease in temperature. However, further adequately powered randomized controlled trials may be required to establish these findings.
Introduction
Intraoperative hypothermia which is defined as a core body temperature < 36°C 1,2 is a common occurrence in surgical patients under anesthesia. OPCABG involves a wide sternotomy, with exposure of the heart and great vessels to the external environment. The duration of OPCABG is also considerably long. These factors favor a net loss of heat from the patient to the cold exterior environment. General anesthesia (GA) administered for OPCABG surgeries further blunts the autonomic responses to maintain the core temperature. 3, 4 Thus, OPCABG patients are vulnerable to develop perioperative hypothermia. OPCABG also involves the use of perioperative vasoactive drugs to maintain the hemodynamic stability. These drugs are known to affect the cutaneous blood flow as well as thermogenesis. These factors may affect the net intraoperative thermal balance in OPCABG patients.
The aim of the study was to observe the temperature changes in patients undergoing elective OPCABG under GA and the influence of vasoactive drugs administered in intraoperative period on the core temperature.
The specific objective was to analyze the core temperature and skin temperature at predefined time points in these patients, and also to compare the core temperature changes in various groups and subgroups depending on the administration of vasoactive drugs.
Subjects and Methods
This was an observational study conducted at a tertiary care cardiac center from January 1, 2014 to October 1, 2014. After ethical clearance from the institutional review board, the study included 151 consenting elective patients undergoing OPCABG under GA.
Adult patients of both sexes were included in the study. Patients aged over 70 years, with thyroid disorders, diabetes mellitus, other endocrine dysfunctions, and fever in the past 2 weeks, with core temperature >37.5°C before induction of anesthesia, and with body mass index (BMI) > 30 or < 20 were excluded.
All patients received general anesthesia with endotracheal intubation. Standard anesthetic technique was used, which included premedication with oral diazepam 5 mg 2 hours prior to surgery, anesthetic induction with a combination of midazolam 5 mg, fentanyl 5 μg/kg, and propofol 30 to 50 mg. Endotracheal intubation was performed after the administration of pancuronium bromide and anesthesia was maintained with isoflorane 0.8% end-tidal concentration, intermittent boluses of fentanyl 2 μg/kg, and volume-controlled ventilation.
Intraoperative Temperature Management
All patients were actively warmed with water mattress with the temperature set at 42°C. Forced air warming devices (Bair hugger) set at 38°C was also used to warm patients throughout the surgery. All intravenous fluids were warmed to 38°C.
Ambient operating room (OR) temperature was maintained at 18 to 20°C. A circle system with a soda lime canister with a heat and moisture exchanger at patient end of the circuit was used in all patients. A gas flow of 1 to 2 L/min was used in all patients. Ventilation was adjusted to maintain an end-tidal carbon dioxide concentration of 35 to 40 mm Hg.
Monitoring
Oxygen saturation, arterial blood pressure, end-tidal carbon dioxide, end-tidal anesthetic gas concentration, central venous pressure, urine output, electrocardiogram, temperature, and arterial blood gases were monitored in all patients.
Measurements
A nasopharyngeal probe was used to measure the core temperature. Skin probe placed on the palmar surface of right index finger was used to measure peripheral temperature. Core temperature, peripheral temperature, and the core to peripheral temperature gradients were recorded every 30 minutes from induction of anesthesia. The readings at end surgery were also recorded. Patient variable age, sex and BMI, as well as the duration of the surgery were also recorded.
Vasoconstrictors and Vasodilators
Dilution for infusion was adrenaline (ADR) 1 mg in 50 mL normal saline (NS), noradrenaline (NORAD) 2 mg in 50 mL NS, dobutamine (DOB) 200 mg in 50 mL NS and nitroglycerine (NTG) 50 mg in 50 mL NS, respectively.
The choice, rate, and timing of the vasoactive infusions were at the discretion of the consultant anesthesiologist and surgeon of the respective OR. Post hoc patients were divided into groups and subgroups. Patients receiving only vasoconstrictors (i.e., ADR or NORAD) intraoperatively were grouped as group V. Patients receiving only vasodilator drugs (i.e., DOB/NTG) intraoperatively were grouped as group D. Patients administered both vasoconstrictors and vasodilators were grouped as group M. Patients who received neither vasoconstrictors nor vasodilators were grouped as group N.
Patients in group V were also divided into subgroups ADR (those receiving ADR) and NORAD (those receiving NORAD). Similarly, the group D was subdivided into subgroups: DOB (those receiving dobutamine) and NTG (those receiving nitroglycerine)
The total dose and mean rate of infusion of vasoactive drugs administered intraoperatively were recorded for patients in group V and group D.
Statistics

Sample Size
Sample size was calculated based on the magnitude of temperature changes observed in OPCABG in previous studies. Expected change in core temperature during OPCABG was within 10%. 5, 6, 7 Therefore, applying the formula:
where p is the expected proportion, d is the absolute precision, and 1-α/2 is the desired confidence level.
By substituting in the formula for a change in temperature of 10%, absolute precision of 5%, and a confidence interval of 95%, the minimum required sample size is 138.
Statistical Analysis
The statistical analysis was done by using STATA 11.1 (StataCorp LLC). The continuous variables of age, duration, core temperature, peripheral temperature, and temperature gradient at different time points of surgery and the total dose of vasoconstrictors and vasodilators were expressed as mean and standard deviation. Students paired t-test was used for core temperature, peripheral temperature, and temperature gradient at different time points and end of surgery for group analysis. Students paired t-test was used for core temperature, peripheral temperature, and temperature gradient at different time points for subgroup analysis (p < 0.05 considered as statistically significant).
Results
A total of 151 patients were included in the study. About 58% of patients were males and the remaining 42% were females. The demographic data and patient variables are listed in the ►Table 1. The study population was divided into groups and subgroups (►Table 1).
All patients showed a decrease in core temperature < 36°C at end surgery (►Table 2). The mean core temperature at end surgery was 35.29 ± 0.24°C. The fall in core temperature followed a characteristic pattern. The decrease in core temperature was rapid in the first hour after induction. This was followed by a more gradual reduction in the core temperature (►Fig. 1)
The skin temperature showed a near linear gradual increase from 34.7 ± 0.08C at induction to 35.22 ± 0.2 C at end surgery.
The temperature gradient decreased from 2.03 ± -0.12 C at induction to 0.06 ± 0.08 C at end surgery.
The study population was divided in four group-group V, group D, group M, and group N-depending on the administration of vasoactive drug infusion during the surgery.
Patients in group V had higher core temperature of 35.50 ± 0.21°C at end surgery. Patients in group D had the lowest end surgery core temperature of 34.97 ± 0.13°C (►Table 3). Subgroups ADR and NORAD showed a similar trend in core temperature fall; however, the core temperatures were higher in group ADR when compared with subgroup NORAD at all time points (►Table 4).
Subgroups DOB and NTG showed similar trends in core temperature changes; however, the core temperature was lower in NTG subgroup when compared with subgroup DOB at all time points (►Fig. 2).
The mean rate of infusion of ADR and NORAD was 2.2 ± 0.38 µg/min and 1 0.6 ± 0.113µg/min, respectively. The mean rate of infusion of DOB and NTG was 259.3 ± 41.32 µg/min and 55.2 ± 13.4µg/min, respectively.
The mean cumulative dose of the vasoactive drug ADR, NORAD, DOB, and NTG was 474.4 µg, 369 µg, 58.5 mg, and 12.342 mg, respectively.
Discussion
Unintentional hypothermia in surgical patients is not uncommon. Depression of central and peripheral thermoregulatory compensation may predispose patients under anesthesia to hypothermia. Redistributive heat loss under anesthesia is due to alteration in the cutaneous blood flow. Cutaneous blood flow determines the flow of heat between core compartment and peripheral compartment. GA lowers the threshold temperature at which thermoregulatory vasoconstriction occurs.
Thus, heat flows from the warmer core compartment to the peripheral compartment. This flow of heat continues till equilibrium is reached or till the thermoregulatory vasoconstriction supervenes.
In this study, 151 patients undergoing elective OPCABG under GA were studied. The ambient OR temperature, age of the patient, BMI, and duration of surgery were comparable in all patients. Intraoperative thermal management, ambient OR temperature, and the anesthetic technique used were also comparable in all patients. The nasopharyngeal temperature and skin temperature at induction were also comparable in all patients. It was observed that the core temperature (measured at the nasopharynx) showed a decreasing trend from induction to end surgery (p < 0.001). This fall in core temperature was steeper in the first 60 minutes after induction. The fall in core temperature in the subsequent intervals was lesser in magnitude. The skin temperature (measured at right index finger) showed a gradual increase from induction to end surgery. The temperature gradient decreased from induction to end surgery.
The changes in core temperature showed variability within the study population. The mean core temperature was significantly higher in group V (Vasoconstrictor group) at all time intervals, when compared with patients in group N (none), group D (vasodilator group), and group M (mixed vasodilator and vasoconstrictor group).
The core temperature was lowest in the group D (vasodilator group). The change in core temperature reflects the normal trends in heat flow under GA. The variability in the changes in core temperature probably reflects the influence of vasoactive drugs on the cutaneous blood flow and hence the redistributive heat loss. These findings may be suggestive of a reduction in redistributive heat loss with the administration of vasoconstrictor drugs and an increase in the same with vasodilator drugs administered intraoperatively.
The changes in skin temperature showed a statistically significant increase from induction to end surgery. The observed changes in peripheral temperature probably reflect the combined effects of redistributive heat gain in peripheral compartment and also the effect of convective warming. The observed temperature changes were variable with the type of vasoactive drug administered. Patients who received DOB had lower core temperature at all time intervals when compared with patients who received NTG. Similarly, in patients who received ADR, the core Abbreviation: SD, standard deviation. Note: Time points-in = induction,1 = 30 mins, 2 = 60 mins, 3 = 90 mins….., end = end surgery. temperatures were higher than those observed in patients who received NORAD. The findings of this study corroborate the findings observed by Goldberg and Roe, 8, 9 Matsukawa et al, 10 and Castillo Monzón et al 11 that most patients had a fall in core temperature; however, the degree of fall in temperature varied from these studies in view of the different monitoring sites, thermal management, type of surgery, and duration of surgery. The pattern of temperature fall was similar to that observed by Matsukawa et al, but of a lesser magnitude.
In this study, the core temperatures were comparable to the forced air warming group in study conducted by Zangrillo Alberto et al, 5 the actively warmed group in the study conducted by Woo et al, 6 and Warm-Touch group in the study conducted by Hofer et al. 7 The core temperature changes observed in group V were comparable with those observed in study by Ikeda et al 12 
Limitations of the Study
• This study was a single center study; thus, a larger multicenter survey and randomized control studies may be necessary to establish the application of the findings in a larger population. • The timing of administration and the dose of vasoactive drugs were variable in the study population thus adding to confounding effects. Further research on the effects of vasoactive drugs may be required to confirm the findings.
Conclusion
Perioperative hypothermia is a known complication in surgeries of long duration like OPCABG. From this study, we conclude that, in OPCABG under GA, the core temperature decreases from induction to end surgery with an initial rapid decrease followed by a gradual decrease. The skin temperature, however, increased gradually from induction to end surgery. Vasoactive drugs might have an influence on the core temperature changes. The vasodilators used perioperatively may further decrease the core temperature, while vasoconstrictor drugs may reduce the magnitude of decrease in core temperature.
Key Message
In OPCABG, core temperature shows a characteristic exponential fall followed by a more gradual fall, while skin temperature gradually increases. The change in core temperature could possibly be modulated by the type and time of vasoactive drugs administered in intraoperative period.
